After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, CTLT falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Catalent Inc. is $10.93B. A total of 1.32 million shares were traded on the day, compared to an average of 1.83M shares.
In the most recent transaction, McErlane David sold 1,994 shares of CTLT for 59.97 per share on Sep 26 ’24. After the transaction, the Group President, Biologics now owns 36,304 company shares. In a previous transaction on Sep 26 ’24, McErlane David bought 2,168 shares at 59.98 per share.
Among the insiders who sold shares, Hopson Ricky disposed of 662 shares on Aug 02 ’24 at a per-share price of $59.56. This resulted in the Pres. BioProduct Delivery, CoS holding 29,974 shares of CTLT after the transaction. In another insider transaction, Gunther Scott sold 666 shares at $59.55 per share on Aug 02 ’24. Company shares held by the SVP, Quality & Reg. Affairs now total 39,635.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CTLT has a high of $61.20 and a low of $31.80.
As of this writing, CTLT has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.19 per share and a lower estimate of -$0.05. The company reported an EPS of -$0.1 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CTLT’s latest balance sheet shows that the firm has $538.00M in Cash & Short Term Investments as of fiscal 2022. There were $4.22B in debt and $1.10B in liabilities at the time. Its Book Value Per Share was $19.91, while its Total Shareholder’s Equity was $4.78B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CTLT is Buy with a score of 3.20.
